CATALENT PHARMA SOLUTIONS, INC. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/eb0dc65a-4948-4aba-8832-e27c646b34cf/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $204.4M | 2012-07-01 – 2013-06-30 | evidence 0001416083-13-000014 |
| FY 2012 | $198.0M | 2011-07-01 – 2012-06-30 | evidence 0001193125-12-378353 |
| FY 2011 | $186.1M | 2010-07-01 – 2011-06-30 | evidence 0001193125-12-378353 |
| FY 2010 | $-61.7M | 2009-07-01 – 2010-06-30 | evidence 0001193125-12-378353 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CATALENT PHARMA SOLUTIONS, INC. — all facts · Revenue · Net Income